News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Apricus Biosciences (APRI) And Its European Partners To Sponsor Symposium On Vitaros® At The European Association Of Urology (EAU) Congress, Stockholm


4/7/2014 9:00:59 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SAN DIEGO, April 7, 2014 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a pharmaceutical company focusing on the development and commercialization of novel therapeutics for men's and women's health, today announced that the Company, along with its European commercial partners, is sponsoring a symposium – "A New Paradigm in the Treatment of ED - The Topical Option" – during the European Association of Urology (EAU) Congress. Vitaros® is Apricus' novel topical on-demand treatment for erectile dysfunction ("ED"), approved in Canada and nine countries in Europe. The symposium will take place in the Stockholmsmassan Exhibition & Convention Center, Room K2, on Friday, April 11 at 4:15 pm DST.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES